Stemline Therapeutics Inc (NASDAQ:STML)

11.82
Delayed Data
As of Jul 01
 +0.05 / +0.42%
Today’s Change
10.50
Today|||52-Week Range
18.94
-30.72%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Revenue and IncomeNet Revenues71.4K71.4K0.000.00
 
 
 
Depreciation And Amortization38.3K38.3K38.3K38.3K
 
 
 
 
 
 
Operating ExpensesGross Income-----38.3K-38.3K
 
 
 
General Expenses6.1M6.9M7.0M7.8M
 
 
 
 
 
Research And Development4.1M5.0M5.1M6.0M
 
 
 
 
 
Total Operating Expenses6.1M7.0M7.1M7.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-6.0M-6.9M-7.1M-7.8M
 
 
 
 
 
Other Expenses-10.5K-8.5K121.6K122.3K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-6.0M-6.9M-6.9M-7.7M
 
 
 
 
 
Net Income-6.0M-6.9M-6.9M-7.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS12.9M13.0M13.0M16.6M
 
 
 
 
 
Shares To Calculate EPS Diluted12.9M13.0M13.0M16.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.47-$0.53-$0.53-$0.46
 
 
 
 
 
EPS Diluted-$0.47-$0.53-$0.53-$0.46
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account